A Guide To The Risks Of Investing In Enveric Biosciences Inc (ENVB)


Enveric Biosciences Inc’s filing revealed that its Director PASQUALONE FRANK acquired Company’s shares for reported $2140.0 on Sep 15 ’23. In the deal valued at $2.14 per share,1,000 shares were bought. As a result of this transaction, PASQUALONE FRANK now holds 1,000 shares worth roughly $1200.0.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance Review of ENVB

On Tuesday, Enveric Biosciences Inc [NASDAQ:ENVB] saw its stock fall -9.09% to $1.20. Over the last five days, the stock has lost -14.89%. Enveric Biosciences Inc shares have fallen nearly -7.69% since the year began. Nevertheless, the stocks have fallen -32.58% over the past one year. While a 52-week high of $6.98 was reached on 02/29/24, a 52-week low of $0.65 was recorded on 02/01/24. SMA at 50 days reached $1.0675, while 200 days put it at $2.0710. A total of 0.63 million shares were traded, compared to the trading of 0.27 million shares in the previous session.

Levels Of Support And Resistance For ENVB Stock

The 24-hour chart illustrates a support level at 1.1025, which if violated will result in even more drops to 1.0049. On the upside, there is a resistance level at 1.3351. A further resistance level may holdings at 1.4701. The Relative Strength Index (RSI) on the 14-day chart is 51.69, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0777, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.52%. Stochastics %K at 23.79% indicates the stock is a holding.

How much short interest is there in Enveric Biosciences Inc?

A steep rise in short interest was recorded in Enveric Biosciences Inc stocks on Feb 29, 2024, growing by 72110.0 shares to a total of 95060.0 shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 22950.0 shares. There was a rise of 75.86%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 3.51% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.01.

Most Popular